{"id":"c7296612-80db-40f4-b7b2-24435edd2bdf","url":"https://x402-filings.datalayer.workers.dev/v1/health/clinical-trials?condition=melanoma&intervention=pembrolizumab&limit=25&phase=PHASE3&sponsor=Novartis&stoppedOnly=true","method":"GET","fingerprint":"6048f323c6e95886dfcf8c1d8d0ec38575184cc4c5f2a2ae9d7b2feba1d61b1b","name":null,"description":null,"category":"other","docs_url":null,"advertised_price_usd":"0.020000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","scheme":"exact","networks":["eip155:8453"],"pay_to":"0x917e635b83F0dd7e8172c55EC4EEbb28B734cA85","input_schema":{"type":"object","required":["type","method"],"properties":{"type":{"type":"string","const":"http"},"method":{"enum":["GET"],"type":"string"},"queryParams":{"type":"object","properties":{"limit":{"type":"integer","examples":[25],"description":"Max studies, 1-100. Default 25."},"phase":{"type":"string","examples":["PHASE3"],"description":"PHASE1, PHASE2, PHASE3 or PHASE4."},"sponsor":{"type":"string","examples":["Novartis"],"description":"Sponsor or collaborator name."},"condition":{"type":"string","examples":["melanoma"],"description":"Condition or disease."},"stoppedOnly":{"type":"boolean","examples":[true],"description":"Only trials that were withdrawn, suspended or terminated. Default true."},"intervention":{"type":"string","examples":["pembrolizumab"],"description":"Drug or intervention name."}}}},"additionalProperties":false},"output_schema":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}},"schema_completeness":0,"status":"live","first_seen_at":"2026-08-23 14:23:00.796786+00","last_seen_at":"2026-08-23 14:22:57.316+00","last_success_at":"2026-09-14 11:47:54.826+00","dead_since":null,"probe_backoff_tier":0,"next_probe_at":"2026-09-14 11:52:54.826+00","search_tsv":"","catalog_number":"5086","x402_version":2,"resource_url":"https://x402-filings.datalayer.workers.dev/v1/health/clinical-trials","resource_description":"Stopped clinical trials with the stop reason classified. ClinicalTrials.gov records why a trial halted as free text; this reads that text and separates safety and efficacy failures from business, recruitment and funding stops, which are the ones people routinely misread as drug failures. Filter by sponsor, condition, intervention and phase, and get the cohort-level breakdown alongside the records.","bazaar_extension":{"info":{"input":{"type":"http","method":"GET","queryParams":{"limit":25,"phase":"PHASE3","sponsor":"Novartis","condition":"melanoma","stoppedOnly":true,"intervention":"pembrolizumab"}},"output":{"type":"json","example":{"count":25,"studies":[{"nctId":"NCT01234567","phase":"PHASE3","title":"Example Phase 3 Study","status":"TERMINATED","sponsor":"Example Biotech","enrollment":210,"stopReason":"recruitment","whyStopped":"Slow accrual","completionDate":"2025-11-30"}],"analysis":{"note":"Only safety and efficacy stops say anything about the drug.","stopReasonBreakdown":{"safety":3,"funding":2,"business":5,"efficacy":7,"recruitment":8,"unclassified":0}},"nextPageToken":null,"totalMatching":118}}},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"type":{"type":"string","const":"http"},"method":{"enum":["GET"],"type":"string"},"queryParams":{"type":"object","properties":{"limit":{"type":"integer","examples":[25],"description":"Max studies, 1-100. Default 25."},"phase":{"type":"string","examples":["PHASE3"],"description":"PHASE1, PHASE2, PHASE3 or PHASE4."},"sponsor":{"type":"string","examples":["Novartis"],"description":"Sponsor or collaborator name."},"condition":{"type":"string","examples":["melanoma"],"description":"Condition or disease."},"stoppedOnly":{"type":"boolean","examples":[true],"description":"Only trials that were withdrawn, suspended or terminated. Default true."},"intervention":{"type":"string","examples":["pembrolizumab"],"description":"Drug or intervention name."}}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}},"accepted_requirements":[{"raw":{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"payTo":"0x917e635b83F0dd7e8172c55EC4EEbb28B734cA85","amount":"20000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":60},"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","payTo":"0x917e635b83F0dd7e8172c55EC4EEbb28B734cA85","scheme":"exact","network":"eip155:8453","amountAtomic":"20000"}],"bazaar_compatible":true,"bazaar_validated_at":"2026-09-14 11:47:54.826+00","bazaar_validation_error":null,"window":"24h","probes_n":23,"handshake_uptime":1,"settle_success_rate":0,"valid_result_rate":null,"latency_p50":634,"latency_p90":4442,"price_drift_pct":0,"score":0.7239,"computed_at":"2026-09-14 11:48:10.246+00","source_metadata":[{"raw":{"url":"https://x402-filings.datalayer.workers.dev/v1/health/clinical-trials?condition=melanoma&intervention=pembrolizumab&limit=25&phase=PHASE3&sponsor=Novartis&stoppedOnly=true","method":"GET","source":"bazaar:api.cdp.coinbase.com","fingerprint":"6048f323c6e95886dfcf8c1d8d0ec38575184cc4c5f2a2ae9d7b2feba1d61b1b","advertisedPriceUsd":0.02},"source_id":1,"external_id":null}],"live_endpoint_metadata":{"x402_version":2,"resource_url":"https://x402-filings.datalayer.workers.dev/v1/health/clinical-trials","resource_description":"Stopped clinical trials with the stop reason classified. ClinicalTrials.gov records why a trial halted as free text; this reads that text and separates safety and efficacy failures from business, recruitment and funding stops, which are the ones people routinely misread as drug failures. Filter by sponsor, condition, intervention and phase, and get the cohort-level breakdown alongside the records.","bazaar_extension":{"info":{"input":{"type":"http","method":"GET","queryParams":{"limit":25,"phase":"PHASE3","sponsor":"Novartis","condition":"melanoma","stoppedOnly":true,"intervention":"pembrolizumab"}},"output":{"type":"json","example":{"count":25,"studies":[{"nctId":"NCT01234567","phase":"PHASE3","title":"Example Phase 3 Study","status":"TERMINATED","sponsor":"Example Biotech","enrollment":210,"stopReason":"recruitment","whyStopped":"Slow accrual","completionDate":"2025-11-30"}],"analysis":{"note":"Only safety and efficacy stops say anything about the drug.","stopReasonBreakdown":{"safety":3,"funding":2,"business":5,"efficacy":7,"recruitment":8,"unclassified":0}},"nextPageToken":null,"totalMatching":118}}},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"type":{"type":"string","const":"http"},"method":{"enum":["GET"],"type":"string"},"queryParams":{"type":"object","properties":{"limit":{"type":"integer","examples":[25],"description":"Max studies, 1-100. Default 25."},"phase":{"type":"string","examples":["PHASE3"],"description":"PHASE1, PHASE2, PHASE3 or PHASE4."},"sponsor":{"type":"string","examples":["Novartis"],"description":"Sponsor or collaborator name."},"condition":{"type":"string","examples":["melanoma"],"description":"Condition or disease."},"stoppedOnly":{"type":"boolean","examples":[true],"description":"Only trials that were withdrawn, suspended or terminated. Default true."},"intervention":{"type":"string","examples":["pembrolizumab"],"description":"Drug or intervention name."}}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}},"accepted_requirements":[{"raw":{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"payTo":"0x917e635b83F0dd7e8172c55EC4EEbb28B734cA85","amount":"20000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":60},"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","payTo":"0x917e635b83F0dd7e8172c55EC4EEbb28B734cA85","scheme":"exact","network":"eip155:8453","amountAtomic":"20000"}],"bazaar_compatible":true,"bazaar_validated_at":"2026-09-14 11:47:54.826+00","bazaar_validation_error":null},"sonar_metrics":{"score":0.7239,"uptime":1,"paid_success_rate":0,"valid_result_rate":null,"latency_p50":634,"latency_p90":4442,"price_drift_pct":0},"cdp_indexed":false,"confidence":"high"}